Decentralized Trial Technology Insights

31. Digital Solutions, Technology, And Patient Care Top Life Science Trends 9/6/2022

    Technology company Within3 has produced a paper on the six top trends that are going to impact the pharmaceutical space. It’s no surprise that technology solutions were one of the trends making the list, but also included were factors such as patients, cyber threats, and a growing global marketplace.

32. Pharma Companies Are Tapping Digital Health For Improved Patient Outcomes 8/11/2022

    Smarter diagnostic tools and a growing role for remote care will be of huge importance in the new paradigm. The pharma industry, which is already growing its role in delivering hybrid solutions combining therapies with diagnostic and smart solutions and devices, could play a significant role here.

33. Tufts Finds Substantial Net Benefits To Using Decentralized Trials 7/28/2022

    For years, vendors have touted decentralized clinical trials (DCTs) as a solution to both the time and cost challenges. DCTs also promise to make trials more patient centric. Unfortunately, a demonstration of the actual benefits of DCTs, along with a quantifiable dollar amount, have been difficult to produce. Until now.

34. How AI/ML Is Helping Clinical Researchers Investigate Alzheimer's 7/28/2022

    Like many cognitive conditions, Alzheimer’s disease can cause changes to a person’s speech and language. Artificial intelligence (AI) and machine learning scientists are working on automating speech assessments to detect the disease earlier and improve understanding of the efficacy of novel treatments. 

35. Your Guide To Harnessing Clinical Trial Sensor Data Better 7/26/2022

    Technological advances in wearables and sensors are speeding the development of digital measures and endpoints. This sensor data is often in native formats unique to each sensor technology and in proprietary clouds owned by the manufacturer. To address this challenge, the Digital Medicine Society released a set of open-access toolkits to support the successful scaling of sensor data to drive better clinical decisions.

36. Decentralized Clinical Trials: Are We Using The Best Terminology For Patients? 7/12/2022

    There is a need within the clinical trials community for a broad term to describe clinical trials that make use of digital health tech and other methods for better accessibility to participants. However, is a single term as helpful for patients as it is for clinical trial professionals?

37. CVS Health Wants To Be Your New Clinical Research Site 7/6/2022

    CVS has been a well-regarded and recognized healthcare brand that started as a pharmacy but has since migrated into a recognized and trusted healthcare company. Now CVS is hoping to expand the relationship it has with patients by moving closer into primary care and clinical trials.

38. Decentralized Clinical Trials: Key Considerations For Sites & PIs 6/21/2022

    As we work to harness the benefits of hybrid and DCTs, sites and investigators must have processes that allow for the acceptance of DCTs and successful implementation. As these policies are under development, the vital viewpoints of sites and PIs are largely overlooked. This article shares these vital viewpoints of sites and PIs.

39. What Does The Future Hold For Decentralized Clinical Trials? 4/20/2022

    What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome? A webinar hosted by IBM Watson hoped to answer that question and many others.

40. The Next Three Years Of Clinical Trials: DCTs, RWE, And Beyond 4/18/2022

    Recent years have seen unprecedented innovation in the clinical space. Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence (AI) and machine learning (ML) are just a few of the reasons to be excited about the future of clinical research.